Literature DB >> 1688439

The 25-kilodalton insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-I-mediated growth of chick embryo pelvic cartilage in vitro.

W M Burch1, J Correa, J E Shively, D R Powell.   

Abstract

Insulin-like growth factor (IGF)-I stimulates the growth of many tissues, including growth plate cartilage. However, the role of IGF-binding proteins in the growth process is controversial. We purified a 25-kDa IGF-binding protein (BP-25) from amniotic fluid. We tested the effect of this BP-25 preparation on both basal and IGF-I-stimulated growth of chick embryo pelvic cartilages maintained in serum-free organ culture. Cartilage wet weight was 4.1 +/- 0.3 mg/cartilage initially; after 3 days, BP-25 inhibited both basal and IGF-I-stimulated growth. Control cartilages weighed 7.4 +/- 0.7 mg/cartilage, while those incubated with 100 nM BP-25 weighed 5.8 +/- 0.5 mg/cartilage (P less than 0.001 vs. control); BP-25 concentrations as low as 0.2 nM significantly inhibited basal cartilage growth. Cartilages incubated with 1.25 nM IGF-I weighed 10.4 +/- 0.8 mg/cartilage (P less than 0.001 vs. control), while those incubated with both 100 nM BP-25 and 1.25 nM IGF-I weighed 8.1 +/- 0.5 mg/cartilage (P less than 0.001 vs. cartilage incubated with IGF-I alone); BP-25 concentrations as low as 0.4 nM significantly inhibited IGF-I-stimulated cartilage growth. BP-25 also inhibited basal and IGF-I-stimulated increases in cartilage dry weight, [3H]thymidine incorporation into DNA, and 35SO4 incorporation into proteoglycan. A second BP-25 preparation, which in the presence of 1% platelet-poor plasma acts synergistically with IGF-I to stimulate DNA synthesis and cell replication of fibroblasts and smooth muscle cells in tissue culture, inhibited IGF-I-stimulated cartilage growth to the same degree as did our BP-25 preparation. In separate experiments, proteins present in serum-free medium conditioned for 3 days by chick cartilages were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to nitrocellulose, and incubated with [125I]IGF-I. This medium was found to contain two IGF-binding proteins; one appeared to be the chick equivalent of BP-25, while the other had a molecular mass similar to that of a poorly characterized human 34-kDa IGF-binding protein. We conclude that purified BP-25 inhibits the growth of chick embryo pelvic cartilage in our serum-free organ culture system. Since conditioned medium from these cartilages contains both IGF-I-like peptides and IGF-binding proteins such as BP-25, we suggest that the IGF-binding proteins present may act to down-regulate the growth-promoting effects of the local IGF peptides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688439     DOI: 10.1210/jcem-70-1-173

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

1.  Damage control mechanisms in articular cartilage: the role of the insulin-like growth factor I axis.

Authors:  J A Martin; M B Scherb; L A Lembke; J A Buckwalter
Journal:  Iowa Orthop J       Date:  2000

2.  Disturbed synthesis of insulinlike growth factor I and its binding proteins may influence renal function changes in liver cirrhosis.

Authors:  C M Fernández-Rodriguez; I Prada; A Andrade; M Moreiras; R Guitián; R Aller; J L Lledó; G Cacho; J Quiroga; J Prieto
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

3.  Growth hormone stimulates the secretion of insulin-like growth factor binding protein-2 (IGFBP-2) by monolayer cultures of sheep costal growth plate chondrocytes.

Authors:  V Borromeo; S Bramani; A T Holder; C Carter; C Secchi; J Beattie
Journal:  Mol Cell Biochem       Date:  1996-09-20       Impact factor: 3.396

Review 4.  IGF-I/IGFBP system: metabolism outline and physical exercise.

Authors:  R Gatti; E F De Palo; G Antonelli; P Spinella
Journal:  J Endocrinol Invest       Date:  2012-06-18       Impact factor: 4.256

5.  Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients.

Authors:  Abdishakur M Abdulle; Michael P T Gillett; Samra Abouchacra; Sufyan M Sabri; Mona Al Rukhaimi; Enyioma N Obineche; Jaipaul Singh
Journal:  Mol Cell Biochem       Date:  2007-03-27       Impact factor: 3.396

6.  Elevated plasma insulin-like growth factor binding protein-1 levels in type 1 (insulin-dependent) diabetic patients with peripheral neuropathy.

Authors:  S R Crosby; C Tsigos; C D Anderton; C Gordon; R J Young; A White
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

7.  Interrelationships between follicle stimulating hormone and the growth hormone--insulin-like growth factor--IGF-binding proteins axes in human granulosa cells in culture.

Authors:  A Barreca; P G Artini; A Cesarone; M Arvigo; G D'Ambrogio; A R Genazzani; G Giordano; F Minuto
Journal:  J Endocrinol Invest       Date:  1996-01       Impact factor: 4.256

8.  Expression and regulation of insulin-like growth factor binding protein-1 in the rat uterus throughout estrous cycle.

Authors:  A Ghahary; J Luo; L J Murphy
Journal:  Mol Cell Biochem       Date:  1993-07-07       Impact factor: 3.396

9.  Insulin-like growth factor-1, growth hormone-dependent insulin-like growth factor-binding protein and growth in children with chronic renal failure.

Authors:  E M Hodson; A S Brown; L P Roy; A R Rosenberg
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

10.  Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence.

Authors:  J I Jones; A Gockerman; W H Busby; G Wright; D R Clemmons
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.